Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings

New BPH module and clinical data reinforce the TULSA Procedure™’s versatility in prostate disease, superior patient benefits, and potential for mainstream adoptionTORONTO, Nov. 28, 2025 (GLOBE ...
News-Medical.Net

Shorter hormone therapy may be enough for many men with prostate cancer

A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of ...
Scientific Research Publishing

Molamba, D.M., Koseka, R.D., Tsita, A.M., Mukaz, P.M., Konga, J.L., Kemfuni, T.M., et al. (2023) Bipolar Transurethral Resection of the Prostate (B-TURP) Including Large ...

ABSTRACT: Introduction: Prostate surgery accounts for a significant proportion of urological surgical procedures. With the advent of endoscopy, conventional surgery has gradually given way to these ...
timesnownews

Breakthrough Drug Combo Increases Aggressive Prostate Cancer Survival by 40%

A new FDA-approved drug brings in a lot of hope for men with aggressive prostate cancer, as it may increase their chances of survival by 40 per cent. According to experts, the combination of two drugs ...
EurekAlert!

Thyroid gland new possible target for prostate cancer treatment

A hormone produced in the thyroid gland can play a key role in the development of prostate cancer. This is shown in a new study by an international research group led by Umeå University, Sweden, and ...